FDA Apporves 1st Sublingual(under the tonuge) Allergy Immunotherapy Treatment

Dear Patients,

The Food and Drug Administration (FDA) has officially approved the first sublingual (under the tongue) allergy immunotherapy treatment options in the United States. Allergy & Asthma Associates wish to call your attention to these products. Oralair contains a five grass tablet mix containing Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass. Grastex tablet contains Timothy grass only. Ragwitex is a ragweed tablet.

  • According to an announcement from the FDA, the prescribing information has a black box warning that severe allergic reactions can occur.

If you wish more information on this new therapy please make an appointment to discuss this further with our doctors.




Dr. Leonard Shapiro & Dr. Boris Lokshin